TAMRO Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home BancShares
HOMB
|
+$15M |
| 2 |
Flotek Industries
FTK
|
+$13.7M |
| 3 |
EMWP
Eros Media World PLC
EMWP
|
+$12.8M |
| 4 |
Travere Therapeutics
TVTX
|
+$11.8M |
| 5 |
ZOES
Zoe's Kitchen, Inc.
ZOES
|
+$10.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HMSY
HMS Holdings Corp.
HMSY
|
+$24.5M |
| 2 |
DexCom
DXCM
|
+$21.3M |
| 3 |
B
Barnes Group Inc.
B
|
+$21.3M |
| 4 |
Hanover Insurance
THG
|
+$20.9M |
| 5 |
Nu Skin
NUS
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.09% |
| 2 | Healthcare | 16.06% |
| 3 | Industrials | 15.05% |
| 4 | Technology | 14.53% |
| 5 | Financials | 12.85% |
Similar funds
TAMRO Capital Partners's Q3 2015 Portfolio in Review
As of Q3 2015, TAMRO Capital Partners held 110 positions worth $880M, down 25% from $1.17B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
TAMRO Capital Partners withdrew a net $204M in Q3 2015, closing 14 positions and reducing 75 holdings. Its most notable exit was HMS Holdings Corp., an estimated $24.5M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, TAMRO Capital Partners opened a new position in Home BancShares worth $15.6M.
- TAMRO Capital Partners's largest Q3 2015 buy was Home BancShares: 770,160 shares worth $15.6M.
- TAMRO Capital Partners added most to Travere Therapeutics in Q3 2015, an estimated $11.8M increase.
- TAMRO Capital Partners's biggest Q3 2015 reduction was DexCom, cutting an estimated $21.3M.
- TAMRO Capital Partners fully exited HMS Holdings Corp. in Q3 2015, selling an estimated $24.5M.
- TAMRO Capital Partners's ten largest holdings make up 26% of its $880M portfolio in Q3 2015.
- TAMRO Capital Partners opened 9 new positions and closed 14 in Q3 2015.
- TAMRO Capital Partners's portfolio value fell 25% quarter-over-quarter to $880M.
Based on TAMRO Capital Partners's 13F filing for Q3 2015, filed 6 Nov 2015.